To be added to the wait list for this event, please call 9667 8181.
Edward Black is the President of Reimbursement Strategies, LLC and will be in Melbourne for the Export Ready for North America Program.
Medical technology has long been a highly regarded and rewarding enterprise. The primary factors that drive industry success have remained the same for years – creative bio-engineering, raising capital, regulatory clearance, clinical studies and publications, quality manufacturing and reimbursement. It has only been with the past three years that medical technology entrepreneurs have identified “reimbursement” as the most significant barrier to new technology adoption in the U.S. market – ahead of FDA regulatory clearance and raising capital.
This seminar will focus on the changing U.S. health care policy as it affects medical technologies and on the reimbursement fundamentals of coding, coverage and payment.
Date: Monday 7th August 2017
Time: Registration from 3:45pm for 4:00pm – 5:15pm session, followed by a networking
Where: Bank of Melbourne, East Podium Lift, Rialto Level 2, 525 Collins Street, Melbourne
Do not book tickets here if your organisation has registered for the Export Ready for North America Program as attendance at this event is included as part of the Program.
BioMelbourne Network Members: $65
Non Members: $130
(Price includes GST)
Bookings are open to BioMelbourne Network Members only until 8am Monday 24th July when they will open for all organisations (unless sold out prior).
To check if your organisation is a member, click here
Edward Black, President, Reimbursement Strategies, LLC
Edward Black specializes in reimbursement strategy, payer relations and health economics for medtech and biotech companies in the US and abroad. He works with companies to commercialize new products and services and has helped clients worldwide navigate the complexities of US healthcare reimbursement. Mr. Black offers a strong understanding of payer perspectives in health policy and excels in translating government and private payer policies into successful reimbursement planning.
Before founding Reimbursement Strategies, LLC in 2008, Mr. Black worked over 25 years in health and provider network management within the Blue Cross Blue Shield system and served on two national advisory boards responsible for leading consistency in medical, benefit, and payment policy. From 1994 to 2002, Edward served as the executive director of three managed care business partnerships with large multispecialty clinics for which he was awarded the 1995 Outstanding Contribution to the Healthcare Industry citation by Medical Alley Association.
Reimbursement Strategies offers the full line of medtech/biotech/pharma reimbursement services including HCPCS and CPT coding analysis and new code submissions; medical coverage policy research, analysis and advocacy; payment negotiation; clinical trial optimization for reimbursement and health economics for new and existing technologies. The company maintains relationships with most medical societies for clinical guideline development and support of CPT and ICD-10 PCS code applications. Mr. Black is active in several US and international medical technology initiatives and is a frequent international lecturer. He is a co-founder and principal in Life Sciences International, Inc. (www.lifesciencesint.com), and serves as an adjunct faculty member in the University of Minnesota Master of Science in Medical Device Innovation Program and Reimbursement Advisor to the University Office for Technology Commercialization.
• The Journal of Urology –Cost of Neuromodulation Therapies for the Treatment of OverActive Bladder: Percutaneous Tibial Nerve Stimulation vs. Sacral Nerve Stimulation; Martinson M, MacDiarmid S, Black E. Vol. 189, 210-216, January 2013 • International Journal of Urogynecology – Cost Effectiveness of Radiofrequency Microremodeling for Stress Urinary Incontinence; Sand PK, Owens GM, Black EJ, Anderson LH, Martinson MS. 2014 Apr;25(4):517-23. doi: 10.1007/s00192-013-2230-8. Epub 2013 Oct 10. • Journal of Medical Economics – Cost-effectiveness of the Convergent Procedure and Catheter Ablation for Non-paroxysmal Atrial Fibrillation. Louise H Anderson, Edward J Black, Kenneth C Civello, Melissa S Martinson, David C Kress. July 2014, Vol 17, No. 7, Pages 481-491
Member: Medical Alley Association, Medical Industry Leadership Institute, Canada-Minnesota Business Council
Program Supported By:
Kindly Hosted By:
Bank of Melbourne isn’t just another bank. For starters, we’re based in Victoria. Headquarters are in the heart of Melbourne. Our branches and corporate banking centres are staffed by locals who know the local neighbourhood – where to find a bargain, a bite to eat or a decent coffee.
Locals talk to each other. So at Bank of Melbourne, banking will be a conversation. Listening to you we can help you find solutions more closely suited to the way you live. No one understands Victorians better.
We’re serious about providing a genuine banking alternative. We have made considerable local investment throughout Victoria. We want to work with you to help you achieve your goals. As you prosper, so will the rest of Victoria.
Victoria deserves a first-class bank of its own. Bank of Melbourne is that bank.